CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1a/1b Trial of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06586515
Title field or adapter rule: {'original_value': 'A Phase 1a/1b Trial of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At: 2026-10-31T23:27:23.052007+00:00
Published At: 2026-10-20T00:00:00+00:00
Record Updated At: 2026-10-20
Source Retrieved At: 2026-10-31T22:17:52.415050+00:00
Timestamp Basis: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions: ["Pancreatic Ductal Adenocarcinoma", "Non-small Cell Lung Cancer", "Colorectal Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct: {"date": "2026-10-20", "type": "ACTUAL"}
protocolSection.identificationModule.nctId: "NCT06586515"
protocolSection.identificationModule.officialTitle: "A Phase 1a/1b Trial of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct: null

Study condition terms

Interventions recorded in this study

{'armGroupLabels': ['Experimental: Phase 1a: LY3962673 Monotherapy', 'Phase 1a: LY3962673 Dose Escalation', 'Phase 1b: LY3962673 Dose Expansion'], 'description': 'Administered orally.', 'name': 'LY3962673', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Phase 1b: LY3962673 Dose Expansion'], 'description': 'Administered intravenously.', 'name': 'Cetuximab', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Phase 1b: LY3962673 Dose Expansion'], 'description': 'Administered intravenously.', 'name': 'Gemcitabine', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Phase 1b: LY3962673 Dose Expansion'], 'description': 'Administered intravenously.', 'name': 'nab-paclitaxel', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Phase 1b: LY3962673 Dose Expansion'], 'description': 'Administered intravenously.', 'name': 'Oxaliplatin', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Phase 1b: LY3962673 Dose Expansion'], 'description': 'Administered intravenously.', 'name': 'leucovorin', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Phase 1b: LY3962673 Dose Expansion'], 'description': 'Administered intravenously.', 'name': 'Irinotecan', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Phase 1b: LY3962673 Dose Expansion'], 'description': 'Administered intravenously.', 'name': '5-fluorouracil', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.